{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-025483","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2023-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.343815+00:00","generated_at":"2026-06-13T04:03:00.256957+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cardiff Oncology grants 50,016 stock options to new employee as inducement","bullets":["Grant of non-qualified stock options for 50,016 shares at $1.49 per share.","Options vest over 4 years: 25% after 1 year, then monthly for 36 months.","Grant made as inducement material to new employee's hiring under Nasdaq Rule 5635(c)(4).","One new employee received the award on July 24, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-025483","json":"https://secwatch.observer/filing/0001628280-23-025483.json","markdown":"https://secwatch.observer/filing/0001628280-23-025483.md","text":"https://secwatch.observer/filing/0001628280-23-025483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/0001628280-23-025483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/crdf-20230724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:03:00.256957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}